Rate My Professor Brent Palmer

His research examines interactions between commensal microbiota and the mucosal immune system in the gut and lung, focusing on their impact on HIV disease progression, T cell function, immune dysfunction, gut microbiome alterations in HIV-positive individuals, antiretroviral treatment effects on immunity and microbiome composition in rural and urban populations, inflammation-associated microbiomes in postacute sequelae of SARS-CoV-2, and diet influences on metabolic health in HIV patients with specific microbiomes. He has published over 85 papers in clinical immunology and host-microbe interactions. Key publications include "IL-37 is a fundamental inhibitor of innate immunity" (Nature Immunology, 2010), "Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells" (Journal of Virology, 2009), "Alterations in the gut microbiota associated with HIV-1 infection" (Cell Host & Microbe, 2013), "Gut microbiome composition influences immunologic alterations in the blood and gut of HIV-positive and HIV-negative men who have sex with men" (Frontiers in Immunology, 2025), and "Inflammation-associated gut microbiome in postacute sequelae of SARS-CoV-2 points towards new therapeutic targets" (Gut, 2024).